Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.200
+0.010 (0.46%)
At close: Oct 6, 2025, 4:00 PM EDT
2.170
-0.030 (-1.36%)
After-hours: Oct 6, 2025, 6:08 PM EDT

Cardiff Oncology Statistics

Total Valuation

CRDF has a market cap or net worth of $146.36 million. The enterprise value is $76.58 million.

Market Cap146.36M
Enterprise Value 76.58M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

CRDF has 66.53 million shares outstanding. The number of shares has increased by 30.91% in one year.

Current Share Class 66.53M
Shares Outstanding 66.53M
Shares Change (YoY) +30.91%
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 2.45%
Owned by Institutions (%) 43.44%
Float 64.90M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 236.31
Forward PS 385.20
PB Ratio 2.50
P/TBV Ratio 2.50
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 140.52
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.02.

Current Ratio 4.42
Quick Ratio 4.29
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -91.93% and return on invested capital (ROIC) is -59.56%.

Return on Equity (ROE) -91.93%
Return on Assets (ROA) -47.90%
Return on Invested Capital (ROIC) -59.56%
Return on Capital Employed (ROCE) -91.98%
Revenue Per Employee $16,515
Profits Per Employee -$1.55M
Employee Count33
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -15.77% in the last 52 weeks. The beta is 1.62, so CRDF's price volatility has been higher than the market average.

Beta (5Y) 1.62
52-Week Price Change -15.77%
50-Day Moving Average 2.27
200-Day Moving Average 3.28
Relative Strength Index (RSI) 51.90
Average Volume (20 Days) 762,295

Short Selling Information

The latest short interest is 15.26 million, so 22.94% of the outstanding shares have been sold short.

Short Interest 15.26M
Short Previous Month 15.91M
Short % of Shares Out 22.94%
Short % of Float 23.51%
Short Ratio (days to cover) 13.67

Income Statement

In the last 12 months, CRDF had revenue of $545,000 and -$51.04 million in losses. Loss per share was -$0.87.

Revenue545,000
Gross Profit -40.86M
Operating Income -54.33M
Pretax Income -51.02M
Net Income -51.04M
EBITDA -53.95M
EBIT -54.33M
Loss Per Share -$0.87
Full Income Statement

Balance Sheet

The company has $70.96 million in cash and $1.19 million in debt, giving a net cash position of $69.77 million or $1.05 per share.

Cash & Cash Equivalents 70.96M
Total Debt 1.19M
Net Cash 69.77M
Net Cash Per Share $1.05
Equity (Book Value) 58.61M
Book Value Per Share 0.88
Working Capital 57.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.85 million and capital expenditures -$26,000, giving a free cash flow of -$41.87 million.

Operating Cash Flow -41.85M
Capital Expenditures -26,000
Free Cash Flow -41.87M
FCF Per Share -$0.63
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -9,969.17%
Pretax Margin -9,361.28%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRDF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -30.91%
Shareholder Yield -30.91%
Earnings Yield -34.88%
FCF Yield -28.61%

Analyst Forecast

The average price target for CRDF is $11.10, which is 404.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.10
Price Target Difference 404.55%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 172.98%
EPS Growth Forecast (5Y) 10.92%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on February 20, 2019. It was a reverse split with a ratio of 1:6.

Last Split Date Feb 20, 2019
Split Type Reverse
Split Ratio 1:6

Scores

CRDF has an Altman Z-Score of -2.61 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.61
Piotroski F-Score 1